Global Virology and Bacteriology Market, By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases, Gastrointestinal, Sexually Transmitted Diseases), By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks), By Region, Competition, Forecast & Opportunities, 2025

August 2020 | 126 pages | ID: GB9811E0F72EEN
TechSci Research

Abstracts

Global virology and bacteriology market is expected to grow at a CAGR of around 12% during 2021 - 2025. The global virology and bacteriology market is driven by rising population getting affected by viral and bacterial infections. Moreover, governments across the globe are investing more on healthcare infrastructure, which is positively impacting the market growth. Also, continuous technological innovations in research and development activities is further expected to bolster the growth of market over the next few years.

The global virology and bacteriology market is segmented based on technology, disease, end user, company, and region. Based on technology, the market can be categorized into molecular diagnostics, immunoassays, diagnostic imaging, and information technology. Out of these, the molecular diagnostics segment dominated the market in 2019 and is expected to maintain its leading position during the forecast period as well. This can be ascribed to the fact that this technology allows the detection of lower amount of infectious agents, thereby detecting the infection at an early stage than was previously possible.

Major players operating in the global virology and bacteriology market include Fujirebio Diagnostics Inc., Cepheid Inc., DiaSorin S.p.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols S.A., Qiagen N.V., Eiken Chemical Co Ltd, Sequenom Inc., bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Corporation, Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche AG, Abbott Laboratories, GSK Biologicals SA among others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers, acquisitions, collaborations and partnerships.

Years considered for this report:

• Historical Years: 2015 - 2018
• Base Year: 2019
• Estimated Year: 2020
• Forecast Period: 2021 – 2025

Objective of the Study:

• To analyze and estimate the market size of global virology and bacteriology market from 2015 to 2018.
• To estimate and forecast the market size of global virology and bacteriology market from 2019 to 2025 and growth rate until 2025.
• To classify and forecast global virology and bacteriology market based on technology, disease, end user, company and regional distribution.
• To identify dominant region or segment in the global virology and bacteriology market.
• To identify drivers and challenges for global virology and bacteriology market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global virology and bacteriology market.
• To identify and analyze the profile of leading players operating in global virology and bacteriology market.
• To identify key sustainable strategies adopted by market players in global virology and bacteriology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global virology and bacteriology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Virology and bacteriology hospitals/clinics, laboratories and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to virology and bacteriology market
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global virology and bacteriology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Market, By Technology:
• Molecular Diagnostics
• Immunoassays
• Diagnostic Imaging
• Information Technology
• Market, By Disease:
• Respiratory System
• Urinary Tract, And Bloodstream Diseases
• Gastrointestinal and Periodontal Diseases
• Sexually Transmitted Diseases
• Market, By Disease:
• Clinics
• Hospitals
• Diagnostic Centers
• Research Laboratories
• Blood Banks
• Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Singapore
• Middle East & Africa
• South Africa
• Saudi Arabia
• Kuwait
• UAE
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global virology and bacteriology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL VIROLOGY AND BACTERIOLOGY MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

6. GLOBAL VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
  6.2.2. By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal Diseases; Sexually Transmitted Diseases)
  6.2.3. By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks)
  6.2.4. By Company (2019)
  6.2.5. By Region
6.3. Market Attractiveness Index

7. ASIA-PACIFIC VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Technology
  7.2.2. By Disease
  7.2.3. By End User
  7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
  7.3.1. China Virology and Bacteriology Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Technology
      7.3.1.2.2. By Disease
      7.3.1.2.3. By End User
  7.3.2. India Virology and Bacteriology Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Technology
      7.3.2.2.2. By Disease
      7.3.2.2.3. By End User
  7.3.3. Japan Virology and Bacteriology Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Technology
      7.3.3.2.2. By Disease
      7.3.3.2.3. By End User
  7.3.4. South Korea Virology and Bacteriology Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Technology
      7.3.4.2.2. By Disease
      7.3.4.2.3. By End User
  7.3.5. Australia Virology and Bacteriology Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Technology
      7.3.5.2.2. By Disease
      7.3.5.2.3. By End User
  7.3.6. Singapore Virology and Bacteriology Market Outlook
    7.3.6.1. Market Size & Forecast
      7.3.6.1.1. By Value
    7.3.6.2. Market Share & Forecast
      7.3.6.2.1. By Technology
      7.3.6.2.2. By Disease
      7.3.6.2.3. By End User

8. EUROPE VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Technology
  8.2.2. By Disease
  8.2.3. By End User
  8.2.4. By Country
8.3. Europe: Country Analysis
  8.3.1. France Virology and Bacteriology Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Technology
      8.3.1.2.2. By Disease
      8.3.1.2.3. By End User
  8.3.2. Germany Virology and Bacteriology Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Technology
      8.3.2.2.2. By Disease
      8.3.2.2.3. By End User
  8.3.3. United Kingdom Virology and Bacteriology Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Technology
      8.3.3.2.2. By Disease
      8.3.3.2.3. By End Use
  8.3.4. Italy Virology and Bacteriology Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Technology
      8.3.4.2.2. By Disease
      8.3.4.2.3. By End User
  8.3.5. Spain Virology and Bacteriology Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Technology
      8.3.5.2.2. By Disease
      8.3.5.2.3. By End User
  8.3.6. Russia Virology and Bacteriology Market Outlook
    8.3.6.1. Market Size & Forecast
      8.3.6.1.1. By Value
    8.3.6.2. Market Share & Forecast
      8.3.6.2.1. By Technology
      8.3.6.2.2. By Disease
      8.3.6.2.3. By End User

9. NORTH AMERICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Technology
  9.2.2. By Disease
  9.2.3. By End User
  9.2.4. By Country
9.3. North America: Country Analysis
  9.3.1. United States Virology and Bacteriology Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Technology
      9.3.1.2.2. By Disease
      9.3.1.2.3. By End User
  9.3.2. Mexico Virology and Bacteriology Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Technology
      9.3.2.2.2. By Disease
      9.3.2.2.3. By End User
  9.3.3. Canada Virology and Bacteriology Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Technology
      9.3.3.2.2. By Disease
      9.3.3.2.3. By End User

10. SOUTH AMERICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Technology
  10.2.2. By Disease
  10.2.3. By End User
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Virology and Bacteriology Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Technology
      10.3.1.2.2. By Disease
      10.3.1.2.3. By End User
  10.3.2. Argentina Virology and Bacteriology Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Technology
      10.3.2.2.2. By Disease
      10.3.2.2.3. By End User
  10.3.3. Colombia Virology and Bacteriology Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Technology
      10.3.3.2.2. By Disease
      10.3.3.2.3. By End Use

11. MIDDLE EAST AND AFRICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Technology
  11.2.2. By Disease
  11.2.3. By End User
  11.2.4. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Virology and Bacteriology Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Technology
      11.3.1.2.2. By Disease
      11.3.1.2.3. By End User
  11.3.2. Saudi Arabia Virology and Bacteriology Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Technology
      11.3.2.2.2. By Disease
      11.3.2.2.3. By End User
  11.3.3. UAE Virology and Bacteriology Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Technology
      11.3.3.2.2. By Disease
      11.3.3.2.3. By End User
  11.3.4. Kuwait Virology and Bacteriology Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Technology
      11.3.4.2.2. By Disease
      11.3.4.2.3. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. PATENT ANALYSIS

15. COMPETITIVE LANDSCAPE

15.1. Fujirebio Diagnostics Inc.
15.2. Cepheid Inc.
15.3. DiaSorin S.p.A.
15.4. Bio-Rad Laboratories Inc.
15.5. Thermo Fisher Scientific Inc.
15.6. Scienion AG
15.7. Grifols S.A.
15.8. Qiagen N.V.
15.9. Eiken Chemical Co. Ltd.
15.10. Sequenom Inc.
15.11. bioMerieux SA
15.12. Siemens AG
15.13. Hologic Inc.
15.14. Diamedix Corporation
15.15. Leica Biosystems Nussloch GmbH
15.16. F. Hoffmann-La Roche AG
15.17. Abbott Laboratories
15.18. GSK Biologicals SA

16. STRATEGIC RECOMMENDATIONS

List Of Figures

LIST OF FIGURES

Figure 1: Global Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 2: Global Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 3: Global Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 4: Global Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 5: Global Virology and Bacteriology Market Size, By Company (USD Million), 2015-2025F
Figure 6: Global Virology and Bacteriology Market Size, By Region (USD Million), 2015-2025F
Figure 7: Global Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 8: North America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 9: North America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 10: North America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 11: North America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 12: North America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
Figure 13: North America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
Figure 14: North America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 15: United States Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 16: United States Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 17: United States Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 18: United States Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 19: United States Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 20: Canada Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 21: Canada Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 22: Canada Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 23: Canada Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 24: Canada Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 25: Mexico Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 26: Mexico Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 27: Mexico Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 28: Mexico Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 29: Mexico Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 30: Europe Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 31: Europe Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 32: Europe Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 33: Europe Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 34: Europe Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
Figure 35: Europe Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
Figure 36: Europe Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 37: France Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 38: France Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 39: France Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 40: France Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 41: France Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 42: Germany Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 43: Germany Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 44: Germany Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 45: Germany Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 46: Germany Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 47: Italy Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 48: Italy Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 49: Italy Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 50: Italy Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 51: Italy Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 52: Spain Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 53: Spain Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 54: Spain Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 55: Spain Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 56: Spain Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 57: United Kingdom Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 58: United Kingdom Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 59: United Kingdom Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 60: United Kingdom Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 61: United Kingdom Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 62: Russia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 63: Russia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 64: Russia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 65: Russia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 66: Russia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 67: Asia-Pacific Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 68: Asia-Pacific Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 69: Asia-Pacific Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 70: Asia-Pacific Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 71: Asia-Pacific Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
Figure 72: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
Figure 73: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 74: China Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 75: China Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 76: China Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 77: China Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 78: China Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 79: India Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 80: India Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 81: India Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 82: India Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 83: India Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 84: Japan Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 85: Japan Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 86: Japan Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 87: Japan Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 88: Japan Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 89: South Korea Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 90: South Korea Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 91: South Korea Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 92: South Korea Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 93: South Korea Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 94: Australia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 95: Australia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 96: Australia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 97: Australia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 98: Australia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 99: Singapore Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 100: Singapore Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 101: Singapore Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 102: Singapore Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 103: Singapore Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 104: Middle East and Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 105: Middle East and Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 106: Middle East and Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 107: Middle East and Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 108: Middle East and Africa Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
Figure 109: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
Figure 110: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 111: South Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 112: South Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 113: South Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 114: South Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 115: South Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 116: Saudi Arabia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 117: Saudi Arabia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 118: Saudi Arabia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 119: Saudi Arabia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 120: Saudi Arabia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 121: Kuwait Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 122: Kuwait Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 123: Kuwait Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 124: Kuwait Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 125: Kuwait Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 126: UAE Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 127: UAE Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 128: UAE Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 129: UAE Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 130: UAE Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 131: South America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 132: South America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 133: South America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 134: South America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 135: South America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
Figure 136: South America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
Figure 137: South America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 138: Brazil Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 139: Brazil Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 140: Brazil Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 141: Brazil Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 142: Brazil Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 143: Argentina Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 144: Argentina Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 145: Argentina Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 146: Argentina Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 147: Argentina Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
Figure 148: Colombia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
Figure 149: Colombia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
Figure 150: Colombia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
Figure 151: Colombia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
Figure 152: Colombia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F

COMPANIES MENTIONED

1.Fujirebio Diagnostics Inc.
2.Cepheid Inc.
3.DiaSorin S.p.A.
4.Bio-Rad Laboratories Inc.
5.Thermo Fisher Scientific Inc.
6.Scienion AG
7.Grifols S.A.
8.Qiagen N.V.
9.Eiken Chemical Co. Ltd.
10.Sequenom Inc.
11.bioMerieux SA
12.Siemens AG
13.Hologic Inc.
14.Diamedix Corporation
15.Leica Biosystems Nussloch GmbH
16.F. Hoffmann-La Roche AG
17.Abbott Laboratories
18.GSK Biologicals SA